85 related articles for article (PubMed ID: 21396479)
1. Salbutamol delays human eosinophil apoptosis via a cAMP-dependent mechanism.
Kankaanranta H; Parkkonen J; Ilmarinen-Salo P; Giembycz MA; Moilanen E
Pulm Pharmacol Ther; 2011 Aug; 24(4):394-400. PubMed ID: 21396479
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase 4 inhibitors delay human eosinophil and neutrophil apoptosis in the absence and presence of salbutamol.
Parkkonen J; Hasala H; Moilanen E; Giembycz MA; Kankaanranta H
Pulm Pharmacol Ther; 2008; 21(3):499-506. PubMed ID: 18282775
[TBL] [Abstract][Full Text] [Related]
3. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.
Dent G; Giembycz MA; Evans PM; Rabe KF; Barnes PJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1167-74. PubMed ID: 7996422
[TBL] [Abstract][Full Text] [Related]
4. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
Seldon PM; Barnes PJ; Meja K; Giembycz MA
Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate.
Kita H; Abu-Ghazaleh RI; Gleich GJ; Abraham RT
J Immunol; 1991 Apr; 146(8):2712-8. PubMed ID: 1707917
[TBL] [Abstract][Full Text] [Related]
6. Desensitization of beta2-adrenoceptor and hypersensitization to phosphodiesterase inhibitors elicited by beta2-agonists in guinea pig eosinophils.
Mio M; Kirino Y; Kamei C
J Allergy Clin Immunol; 2000 Nov; 106(5):896-903. PubMed ID: 11080712
[TBL] [Abstract][Full Text] [Related]
7. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
Blease K; Burke-Gaffney A; Hellewell PG
Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
[TBL] [Abstract][Full Text] [Related]
8. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA
Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646
[TBL] [Abstract][Full Text] [Related]
9. Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro.
Juergens UR; Stöber M; Libertus H; Darlath W; Gillissen A; Vetter H
Eur J Med Res; 2004 Jul; 9(7):365-70. PubMed ID: 15337638
[TBL] [Abstract][Full Text] [Related]
10. Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels.
Tomlinson PR; Wilson JW; Stewart AG
Biochem Pharmacol; 1995 Jun; 49(12):1809-19. PubMed ID: 7598743
[TBL] [Abstract][Full Text] [Related]
11. Role of cAMP-dependent pathway in eosinophil apoptosis and survival.
Chang HS; Jeon KW; Kim YH; Chung IY; Park CS
Cell Immunol; 2000 Jul; 203(1):29-38. PubMed ID: 10915559
[TBL] [Abstract][Full Text] [Related]
12. Rolipram, salbutamol and prostaglandin E2 suppress TNFalpha release from human monocytes by activating Type II cAMP-dependent protein kinase.
Seldon PM; Meja KK; Giembycz MA
Pulm Pharmacol Ther; 2005; 18(4):277-84. PubMed ID: 15777610
[TBL] [Abstract][Full Text] [Related]
13. Does cyclic AMP mediate rat urinary bladder relaxation by isoproterenol?
Frazier EP; Mathy MJ; Peters SL; Michel MC
J Pharmacol Exp Ther; 2005 Apr; 313(1):260-7. PubMed ID: 15576470
[TBL] [Abstract][Full Text] [Related]
14. Effect of beta2-adrenergic agonists on eosinophil adhesion, superoxide anion generation, and degranulation.
Noguchi T; Nakagome K; Kobayashi T; Ueda Y; Soma T; Nakamoto H; Nagata M
Allergol Int; 2015 Sep; 64 Suppl():S46-53. PubMed ID: 26344080
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of salbutamol and montelukast on eosinophil adhesion and superoxide anion generation.
Kushiya M; Saito K; Kikuchi I; Kobayashi T; Hagiwara K; Kanazawa M; Nagata M
Int Arch Allergy Immunol; 2006; 140 Suppl 1():17-22. PubMed ID: 16772722
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF.
Hallsworth MP; Giembycz MA; Barnes PJ; Lee TH
Br J Pharmacol; 1996 Jan; 117(1):79-86. PubMed ID: 8825346
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
Torphy TJ; Zhou HL; Cieslinski LB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
[TBL] [Abstract][Full Text] [Related]
19. beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells.
Hallsworth MP; Twort CH; Lee TH; Hirst SJ
Br J Pharmacol; 2001 Feb; 132(3):729-41. PubMed ID: 11159726
[TBL] [Abstract][Full Text] [Related]
20. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
